menu
    • menu

    Company profile for QOL Medical

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    QOL Medical is a specialty biopharmaceutical company dedicated to improving clinical outcomes and overall quality of life for patients with rare diseases. QOL Medical is a patient-centric company founded in 2003 to focus on the acquisition and commercialization of orphan and gastrointestinal products in underserved markets.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    QOL MedicalUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3405 Ocean Drive Vero Beach, FL 32963
    Telephone
    Telephone
    1-866-469-3773
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.qolmed.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Evoke Pharma And QOL Medical Announce Expiration Of Tender Offer
    Evoke Pharma And QOL Medical Announce Expiration Of Tender Offer

    17 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/evoke-pharma-and-qol-medical-announce-expiration-of-tender-offer-302644883.html

    PR NEWSWIRE
    17 Dec 2025
    Share Share
    QOL Medical CEO Increases Faith-Based Donations
    QOL Medical CEO Increases Faith-Based Donations

    31 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/derick-cooper-ceo-of-qol-medical-llc-strengthens-commitment-to-faith-based-giving-with-major-donations-to-religious-organizations-302420591.html

    PR NEWSWIRE
    31 Mar 2025
    Share Share
    QOL Medical CEO Donates $75,000 to Beacon Rescue and Relief
    QOL Medical CEO Donates $75,000 to Beacon Rescue and Relief

    21 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/derick-cooper-ceo-of-qol-medical-llc-donates-75-000-to-support-beacon-rescue-and-disaster-relief-efforts-302407739.html

    PR NEWSWIRE
    21 Mar 2025
    Share Share
    FDA-Approved Sucraid Offers Free 4-Day Trial for CSID Treatment
    FDA-Approved Sucraid Offers Free 4-Day Trial for CSID Treatment

    01 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sucraid-sacrosidase-oral-solution-free-4-day-trial-now-available-the-only-fda--approved-therapy-to-treat-csid-congenital-sucrase-isomaltase-deficiency-302389214.html

    PR NEWSWIRE
    01 Mar 2025
    Share Share
    QOL MEDCL`s Biologic Sucraud (Sacrosidase) Receives Suppl Approvals in US
    QOL MEDCL`s Biologic Sucraud (Sacrosidase) Receives Suppl Approvals in US

    02 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020772

    FDA
    02 Aug 2024
    Share Share
    QOL Medical, LLC receives FDA approval of Sucraid
    QOL Medical, LLC receives FDA approval of Sucraid

    06 Sep 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/qol-medical-llc-receives-fda-approval-of-sucraid-sacrosidase-oral-solution-single-use-containers-for-patients-with-congenital-sucrase-isomaltase-deficiency-csid-301618690.html

    PRNEWSWIRE
    06 Sep 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search